First Diagnostic Corp. is a leading developer and manufacturer of advanced rapid point‑of‑care (POC) diagnostic systems. Our technology portfolio is engineered to deliver high‑sensitivity, high‑specificity results within minutes, supporting accelerated clinical decision‑making across diverse care environments.
We design and commercialize professional‑use assays that address critical needs in infectious disease, cardiology, oncology, drugs of abuse testing, and women’s health. Our platforms integrate optimized immunoassay chemistry, precision‑engineered test architectures, and rigorous quality‑system controls to ensure consistent analytical performance and reproducibility.
First Diagnostic has established a strong market presence through its proprietary product lines, ATFirst™ and inSTIcheck™, which are recognized for their reliability, operational simplicity, and validated clinical accuracy. These brands form the foundation of our expanding professional diagnostics franchise and are widely adopted across point‑of‑care, urgent care, and decentralized testing settings.
Our mission is to advance rapid diagnostics that enhance patient triage, streamline clinical workflows, and improve real‑world health outcomes.
Connect with our team to explore how First Diagnostic Corp. can support your organization with next‑generation POC testing solutions built for precision, speed, and clinical impact.
